Lauren L. Ritterhouse

Author

Massachusetts General Hospital ORCID

Also Known As

L. Ritterhouse, Lauren L Ritterhouse, Lauren L. Ritterhouse, Lauren Ritterhouse, Sabah Kadri

160

Publications

6.4K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University University of Chicago Brigham and Women's Hospital Dana-Farber Cancer Institute

About

Lauren L. Ritterhouse is an author at Massachusetts General Hospital specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.7K
2	Health Sciences	3	3	52
3	Natural Sciences	2	2	80
4	Engineering	1	1	13
5	Public Health	1	1	153

Lauren L. Ritterhouse

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Cancer Discovery	2016	1.1K
Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1 Brooke E. Howitt, Sachet A. Shukla, Lynette M. Sholl, JAMA Oncology	2015	666
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer Kyle C. Strickland, Brooke E. Howitt, Sachet A. Shukla, Oncotarget Neoantigen LoadBrca1/2-mutation StatusCancer ImmunosurveillanceTumor HeterogeneityMedicine	2016	612
Institutional implementation of clinical tumor profiling on an unselected cancer population Lynette M. Sholl, T. Khanh, Priyanka Shivdasani, JCI Insight	2016	434
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Sara M. Tolaney, Hao Guo, Sònia Pernas, Journal of Clinical Oncology	2019	276
Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus Lauren L. Ritterhouse, S. R. Crowe, Timothy B. Niewold, Annals of the Rheumatic Diseases	2011	226
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma Vasiliki Panou, Meghana Gadiraju, Arthur Wolin, Journal of Clinical Oncology	2018	222
Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital Tyler E. Miller, Wilfredo F. Garcia Beltran, Adam Z. Bard, The FASEB Journal Viral DiagnosticsDiagnosisDiagnosticsCovid-19 EpidemiologyCovid-19	2020	153
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma Jonathan Trujillo, Jason J. Luke, Yuanyuan Zha, Journal for ImmunoTherapy of Cancer	2019	145
ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non–Small Cell Lung Cancer Lauren L. Ritterhouse, Siraj M. Ali, Mark Bailey, Journal of Thoracic Oncology Other Oncogenic DriversOncologyOncogenic AgentMedicineCancer Cell Biology	2017	127

Page 1